Androgens are directly secreted by the ovaries and adrenals in women, and androgen precursors from these glands are converted in a variety of peripheral tissues into androgens. The major androgen in women is testosterone, and its action in target tissues can be mediated through the androgen receptor or through the estrogen receptor after aromatization to estradiol. Low sexual desire that causes...

Although there is an abundant debate regarding the mechanisms sustaining one of the most common sexual complaints among women, i.e., female hypoactive sexual desire disorder (HSDD), little remains known about the specific neural bases of this disorder. BIANCHI-DEMICHELI, Francesco, et al. Neural bases of hypoactive sexual desire disorder in women: an event-related fMRI study. Journal of Sexual ...

Abstract Introduction Hyposexual desire disorder (HSDD) is a common female sexual health problem. HSDD mainly refers to women's continuous lack of fantasy or for activities, accompanied by obvious personal pain affecting the partnership. In humans, regulated variety neurotransmitters in key areas brain. Norepinephrine, dopamine, melanocortin, oxytocin and vasopressin mediate excitability, while...

Objective: Hypoactive sexual desire Disorder (HSDD) is a common sexual problem among women. Sexual interest and desire inventory -female (SIDI-F) has been widely validated and used to measure sexual desire in women. The aim of this study was to determine the psychometric properties of the Persian version of SIDI-F for Iranian population. Method: This was a methodological study on the psychometr...

INTRODUCTION The complex condition of the menopause is experienced by all women going through the physical and emotional changes associated with ovarian sexual hormones loss. It may impact directly on their physical and mental health. AIM The complexity of this condition makes it necessary to accumulate large bodies of data to define the patterns and trends in its evaluable manifestations. To...

Flibanserin is the first US Food and Drug Administration (FDA)-approved option for sexual dysfunction, specifically low sexual desire. Until recently, there were no FDA-approved medication options to assist the ~40% of women affected by female sexual dysfunction (FSD). Often, patients report feeling uncomfortable discussing sexual health, identifying a strong need for health care professionals ...

Imagine a forty-five-year-old woman who has been happily married for fifteen years presenting to her physician with complaints of infrequent sexual thoughts and fantasies. 1 After a history and physical examination, the physician diagnoses her as having low sexual desire. 2 But does she have an actual disease? A few decades ago, this woman would not have had a recognizable disease, and there wa...

objective: hypoactive sexual desire disorder (hsdd) is a common sexual problem among women. sexual interest and desire inventory –female (sidi-f) has been widely validated and used to measure sexual desire in women. the aim of this study was to determine the psychometric properties of the persian version of sidi-f for iranian population. method: this was a methodological study on the psychometr...

It is increasingly apparent that social media is a unique and important resource to explore spontaneous relations and discourses among individuals. Data analysis in social media, however, is difficult because approaches have not been streamlined. In this paper, we move from the discussion of present perspectives in the analysis of social media to then discuss the methodological strategies avail...

Abstract Introduction Flibanserin was the first FDA approved drug for hypoactive sexual desire disorder (HSDD) in premenopausal women, but initially studied as an antidepressant without concern age or gender. acts partial agonist at serotonin receptor 1A and antagonist 2A receptor. The mechanism of action is thought to be due increase dopamine norepinephrine. Post hoc analysis during pivotal tr...